Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate Risk Prostate Cancer (Diagnosis)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01368055
What this trial is testing

Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Florida 361
Testing effectiveness (Phase 2)WithdrawnNCT01409473
What this trial is testing

Stereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Rocky Mountain Cancer Centers
Not applicableLooking for participantsNCT04035642
What this trial is testing

Single-Dose Image-Guided Radiotherapy With Urethral Sparing and DIL Boost for Intermediate-Risk Prostate Cancer (PROSINT II)

Who this might be right for
Prostate Cancer
Fundacao Champalimaud 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04597359
What this trial is testing

To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

Who this might be right for
Prostate Carcinoma
ECOG-ACRIN Cancer Research Group 360
Large-scale testing (Phase 3)Active Not RecruitingNCT00223145
What this trial is testing

Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone

Who this might be right for
Prostate Cancer
Abdenour Nabid 600
Early research (Phase 1)Study completedNCT03269422
What this trial is testing

Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL)

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 35
Not applicableActive Not RecruitingNCT05668351
What this trial is testing

Stereotactic Ablative Radiation Therapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of South Carolina 42
Testing effectiveness (Phase 2)Looking for participantsNCT07302451
What this trial is testing

REDI-CaP(Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients)

Who this might be right for
Prostate Cancer (Adenocarcinoma)
National Cancer Institute, Naples 50
Not applicableStudy completedNCT04087980
What this trial is testing

Ablation of Prostate Tissue Utilizing Sterile Water Vapor in Patients With Intermediate Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Francis Medical Inc. 26
Not applicableWithdrawnNCT04399824
What this trial is testing

Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage II Prostate Cancer AJCC v8+3 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01530269
What this trial is testing

C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma

Who this might be right for
Prostate CancerProstate Adenocarcinoma
Phoenix Molecular Imaging 300
Not applicableLooking for participantsNCT06200974
What this trial is testing

Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer

Who this might be right for
Localized Prostate Carcinoma
British Columbia Cancer Agency 100
Not applicableUnknownNCT04462926
What this trial is testing

Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed

Who this might be right for
Prostate CancerProstatic NeoplasmUrogenital Neoplasms+3 more
Azienda Ospedaliero-Universitaria di Modena 100
Not applicableActive Not RecruitingNCT02623933
What this trial is testing

MRI Assisted Focal Boost With HDR Monotherapy for Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Sunnybrook Health Sciences Centre 60
Not applicableStudy completedNCT00898326
What this trial is testing

PSA Levels and Biopsy Samples After Implant Radiation and Hormone Therapy in Patients With Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 198
Testing effectiveness (Phase 2)Ended earlyNCT03211052
What this trial is testing

Neoadjuvant TAK-700 and Leuprorelin Acetate Followed by Surgery Versus Surgery Alone

Who this might be right for
Prostate Cancer
Centre of Experimental Medicine 16
Not applicableNot Yet RecruitingNCT06916013
What this trial is testing

Focal Laser Ablation in Prostate Cancer

Who this might be right for
Prostate CancerLaser
Ain Shams University 30
Not applicableActive Not RecruitingNCT07455097
What this trial is testing

COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)

Who this might be right for
Intermediate-risk Prostate CancerHigh-risk Prostate Cancer
Heinrich-Heine University, Duesseldorf 600
Not applicableNot Yet RecruitingNCT07460726
What this trial is testing

PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)Erectile AbnormalitiesSexual Dysfunction Male
CancerCare Manitoba 130
Not applicableUnknownNCT05073653
What this trial is testing

68Ga-GRP PET/CT for Imaging in Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Xiangya Hospital of Central South University 80
Next Page